HIGHLIGHTS
- who: Badri from the Department of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China have published the paper: Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets, in the Journal: (JOURNAL)
- what: The authors explored the potential carcinogenic role of SHCBP1 across 33 tumors from the TCGA and GTEx databases. The authors explored and verified the potential roles of SHCBP1 in cancer development and progression via pan-cancer analysis, focusing on expression, prognosis, genetic alterations, protein phosphorylation, immune infiltration, and other relevant cellular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.